指南与共识儿童感染儿童呼吸

通过循证指南安全减少儿童严重过敏反应住院率

Safely Reducing Hospitalizations for Anaphylaxis in Children Through an Evidence-Based Guideline.
指南 / 共识 · Pediatrics · 2022-01-01

该质量改进项目在某三级儿童教学医院实施多管齐下干预策略,包括修订的循证指南,使用改进模型和统计过程控制评估关键指标变化。结果显示住院率从28.5%显著降至11.2%,西替利嗪使用比例从4.2%升至59.7%,无哮喘患者皮质类固醇使用从72.6%降至32.4%,72小时非计划再访保持稳定。

要点

  • 实施循证指南后儿童严重过敏反应住院率从28.5%降至11.2%,降幅17.3%。
  • 西替利嗪使用比例从4.2%升至59.7%,无哮喘患者皮质类固醇使用从72.6%降至32.4%。
  • 72小时非计划再访作为平衡措施保持稳定,表明减少住院未增加再访风险。

核心结论

  • 通过本地循证指南结合结局监测和持续反馈,可安全将儿童严重过敏反应住院率降低17.3%而不增加72小时再访。

研究设计与样本

  • 在某三级儿童教学医院开展质量改进项目,采用改进模型和多管齐下干预策略,使用统计过程控制评估关键指标变化。

主要发现

  • 住院率从实施前的28.5%显著降至实施期间的11.2%。
  • 西替利嗪使用比例从4.2%显著升至59.7%。
  • 无哮喘患者皮质类固醇使用从72.6%显著降至32.4%。
  • 符合住院时长标准的患者比例从53.3%升至59.9%。
  • 72小时非计划再访作为平衡措施保持稳定。

关键数值与推荐

  • 住院率从28.5%降至11.2%,降幅17.3%。
  • 西替利嗪使用比例从4.2%升至59.7%。
  • 无哮喘患者皮质类固醇使用从72.6%降至32.4%。
  • 符合住院时长标准的患者比例从53.3%升至59.9%。

临床怎么用

  • 采用本地循证指南指导儿童严重过敏反应管理,可安全减少不必要的住院。
  • 结合结局监测和持续反馈给临床医生,有助于改善严重过敏反应管理。

局限性

  • 研究为单中心质量改进项目,全国住院率也在下降,可能影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emergency department visits for anaphylaxis have increased considerably over the past few decades, especially among children. Despite this, anaphylaxis management remains highly variable and contributes to significant health care spending. On the basis of emerging evidence, in this quality improvement project we aimed to safely decrease hospitalization rates, increase the use of cetirizine, and decrease use of corticosteroids for children with anaphylaxis by December 31, 2019. METHODS: A multipronged intervention strategy including a revised evidence-based guideline was implemented at a tertiary children's teaching hospital by using the Model for Improvement. Statistical process control was used to evaluate for changes in key measures. Length of stay and unplanned return visits within 72 hours were monitored as process and balancing measures, respectively. As a national comparison, hospitalization rates were compared with other hospitals' data from the Pediatric Health Information System. RESULTS: Hospitalizations decreased significantly from 28.5% to 11.2% from preimplementation to implementation, and the balancing measure of 72-hour revisits was stable. The proportion of patients receiving cetirizine increased significantly from 4.2% to 59.7% and use of corticosteroids decreased significantly from 72.6% to 32.4% in patients without asthma. The proportion of patients meeting length of stay criteria increased from 53.3% to 59.9%. Hospitalization rates decreased nationally over time. CONCLUSIONS: We reduced hospitalizations for anaphylaxis by 17.3% without concomitant increases in revisits, demonstrating that unnecessary hospitalizations can be safely avoided. The use of a local evidence-based guideline paired with close outcome monitoring and sustained messaging and feedback to clinicians can effectively improve anaphylaxis management.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Gaffney LK, Porter J, Gerling M, et al. Safely Reducing Hospitalizations for Anaphylaxis in Children Through an Evidence-Based Guideline. Pediatrics. 2022. PMID: 35059724. doi:10.1542/peds.2020-045831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。